Candida species frequently cause bloodstream infections, yet there's lack of epidemiological studies on candidemia in Oman. To address this, we conducted a retrospective study at Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC) from October 2021 to October 2023. Our study identified 27 episodes of candidemia among 26 cancer patients, with an incidence of 4.9 per 1000 admissions. Non-albicans Candida (NAC) prevailed over C. albicans (70.37% vs. 29.62%), with C. glabrata as the predominant NAC species (n = 10; 37%). The 30-day mortality rate was 40.7%, showing no significant difference between NAC and C. albicans, but was notably higher in critically ill patients (p-value = 0.03).
No takes yet. Share an insight, caveat, or question.
Awada et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: